Tidal Investments’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.02M | Buy |
51,399
+3,495
| +7% | +$273K | 0.02% | 473 |
|
2025
Q1 | $3.47M | Buy |
47,904
+934
| +2% | +$67.7K | 0.03% | 480 |
|
2024
Q4 | $3.48M | Buy |
46,970
+7,438
| +19% | +$551K | 0.03% | 487 |
|
2024
Q3 | $2.61M | Buy |
39,532
+275
| +0.7% | +$18.1K | 0.03% | 512 |
|
2024
Q2 | $3.63M | Buy |
39,257
+9,012
| +30% | +$832K | 0.05% | 328 |
|
2024
Q1 | $2.89M | Buy |
30,245
+10,700
| +55% | +$1.02M | 0.05% | 382 |
|
2023
Q4 | $1.49M | Buy |
19,545
+1,291
| +7% | +$98.4K | 0.03% | 463 |
|
2023
Q3 | $1.26M | Buy |
18,254
+2,909
| +19% | +$202K | 0.04% | 471 |
|
2023
Q2 | $1.45M | Sell |
15,345
-244
| -2% | -$23K | 0.04% | 416 |
|
2023
Q1 | $1.29M | Buy |
15,589
+1,059
| +7% | +$87.6K | 0.04% | 403 |
|
2022
Q4 | $1.08M | Buy |
14,530
+1,179
| +9% | +$88K | 0.04% | 419 |
|
2022
Q3 | $1.1M | Buy |
13,351
+698
| +6% | +$57.7K | 0.05% | 346 |
|
2022
Q2 | $1.2M | Buy |
12,653
+159
| +1% | +$15.1K | 0.04% | 338 |
|
2022
Q1 | $1.47M | Buy |
12,494
+1,553
| +14% | +$183K | 0.04% | 317 |
|
2021
Q4 | $1.42M | Buy |
10,941
+1,894
| +21% | +$245K | 0.04% | 309 |
|
2021
Q3 | $1.02M | Buy |
9,047
+1,397
| +18% | +$158K | 0.04% | 328 |
|
2021
Q2 | $792K | Buy |
7,650
+2,396
| +46% | +$248K | 0.03% | 339 |
|
2021
Q1 | $439K | Buy |
5,254
+1,048
| +25% | +$87.6K | 0.02% | 326 |
|
2020
Q4 | $384K | Buy |
4,206
+747
| +22% | +$68.2K | 0.03% | 267 |
|
2020
Q3 | $276K | Buy |
3,459
+417
| +14% | +$33.3K | 0.04% | 202 |
|
2020
Q2 | $210K | Buy |
+3,042
| New | +$210K | 0.03% | 281 |
|